EVALUATION OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) PALONOSETRON IN CANCER PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY: A RANDOMIZED PHARMACOKINETIC ASSAY

被引：0
|
作者：
Arevalo, E. [1 ]
Del Barrio, A. [1 ]
Sadaba, B. [1 ]
Campanero, M. A. [1 ]
Azanza, J. R. [1 ]
Gurpide, A. [1 ]
Lopez Picazo, J. M. [1 ]
Martin Algarra, S. [1 ]
Perez Gracia, J. L. [1 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [21] Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Mellema, Wouter W.
    van der Hoek, Dorien
    Postmus, Pieter E.
    Smit, Egbert F.
    LUNG CANCER, 2014, 86 (01) : 73 - 77
  • [22] ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy
    Bamias, A.
    Nikitas, N.
    Karadimou, A.
    Gika, D.
    Karavasilis, V.
    Briasoulis, E. C.
    Chrisofos, M.
    Murray, S.
    Pectasides, D. G.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
    Fossa, SD
    Oliver, RTD
    Stenning, SP
    Horwich, A
    Wilkinson, P
    Read, G
    Mead, GM
    Roberts, JT
    Rustin, G
    Cullen, MH
    Kaye, SB
    Harland, SJ
    Cook, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (09) : 1380 - 1387
  • [24] Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy
    Karageorgopoulou, Sofia
    Kostakis, Ioannis D.
    Gazouli, Maria
    Markaki, Sonia
    Papadimitriou, Marios
    Bournakis, Evangelos
    Dimopoulos, Meletios-Athanassios
    Papadimitriou, Christos A.
    BMC CANCER, 2017, 17
  • [25] XPF polymorphism toward lung cancer susceptibility and survival in patients treated with platinum-based chemotherapy
    Lawania, Shweta
    Sharma, Siddharth
    Singh, Navneet
    Behera, Digamber
    FUTURE ONCOLOGY, 2018, 14 (11) : 1071 - 1089
  • [26] Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    Shepherd, FA
    Dancey, J
    Ramlau, R
    Mattson, K
    Gralla, R
    O'Rourke, M
    Levitan, N
    Gressot, L
    Vincent, M
    Burkes, R
    Coughlin, S
    Kim, Y
    Berille, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) : 2095 - 2103
  • [27] Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy
    Jin, Juan
    Zhang, Wenwen
    Ji, Wenfei
    Yang, Fang
    Guan, Xiaoxiang
    CANCER BIOLOGY & THERAPY, 2017, 18 (06) : 369 - 378
  • [28] Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Zou, Ting
    Liu, Jun-Yan
    Qin, Qun
    Guo, Jie
    Zhou, Wen-Zhi
    Li, Xiang-Ping
    Zhou, Hong-Hao
    Chen, Juan
    Liu, Zhao-Qian
    BIOMEDICINES, 2023, 11 (12)
  • [29] Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy
    Chuchu Zhao
    Saisai Li
    Menghuang Zhao
    Haiyan Zhu
    Xueqiong Zhu
    Archives of Gynecology and Obstetrics, 2018, 297 : 153 - 159
  • [30] DOCETAXEL VERSUS GEFTINIB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC PRE-TREATED WITH PLATINUM-BASED CHEMOTHERAPY
    Bhatnagar, A. R.
    Singh, D. P.
    Sharma, R.
    Kumbhaj, P.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S159 - S159
12345